May 12th 2025
The survey asked about patient cannabis use, openness to discussing cannabis as part of treatment plans, and perspectives on substance use of physicians.
Cannabinoids in a Pill? One Company’s Research to Find the Next Cannabinoid-Based Medication
May 10th 2022Dr. Woody, chief executive officer of 180 Life Sciences, discusses in this interview the current research surrounding synthetic cannabinoids as a treatment for chronic pain, as well as the development of a new type of medication that would have the potential to offer the benefits of cannabis without any undesirable effects.
A Doctor’s Fight for Cannabis Reform and Regulation
December 23rd 2021Peter Grinspoon, MD, a primary care physician at Massachusetts General Hospital and an instructor in medicine at Harvard Medical School, shares his knowledge on medical cannabis, issues facing the industry, and hopes for the future.
Medical Cannabis Insights, Part III: Medical Cannabis for Pain, Anxiety, ADHD, and More
September 27th 2021In this roundtable interview series, we speak to the organizers of the CannMed Medical Practicum—Bonni Goldstein, MD; Dustin Sulak, DO; Kevin Spelman, PhD, MCPP; and Eloise Theisen, NP, AGPCNP-BC— to learn more about them and what attendees can expect from the practicum. Here in part III, they discuss how cannabis is used to treat acute and chronic pain, anxiety, ADHD, and pediatric patients.